La Flucytosine en 1984

Translated title of the contribution: Flucytosine in 1984

J. E. Bennett

Research output: Contribution to journalArticle

Abstract

Flucytosine is an effective drug in experimental crytococcosis and candidiasis but clinical experience has encountered excessive failures, many of which are traceable to drug resistence. Additional of low dosage amphotericin B has largely solved the problem of drug resistence but has encountered flucytosine toxicity to bone marrow and intestine. Careful monitoring of flucytosine blood levels is essential in patients with azotemia due to amphotericin B.

Original languageFrench
Pages (from-to)332-336
Number of pages5
JournalMedecine et Maladies Infectieuses
Volume15
Issue number6
DOIs
StatePublished - 1985
Externally publishedYes

Fingerprint

Flucytosine
Amphotericin B
Pharmaceutical Preparations
Azotemia
Candidiasis
Intestines
Bone Marrow

Keywords

  • 5-fluorocytosine
  • 5-fluorouracil
  • Candidiasis-Cryptococcosis
  • Flucytosine

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

La Flucytosine en 1984. / Bennett, J. E.

In: Medecine et Maladies Infectieuses, Vol. 15, No. 6, 1985, p. 332-336.

Research output: Contribution to journalArticle

Bennett, J. E. / La Flucytosine en 1984. In: Medecine et Maladies Infectieuses. 1985 ; Vol. 15, No. 6. pp. 332-336.
@article{d7565d56c12c42aba10991ae418c2fa5,
title = "La Flucytosine en 1984",
abstract = "Flucytosine is an effective drug in experimental crytococcosis and candidiasis but clinical experience has encountered excessive failures, many of which are traceable to drug resistence. Additional of low dosage amphotericin B has largely solved the problem of drug resistence but has encountered flucytosine toxicity to bone marrow and intestine. Careful monitoring of flucytosine blood levels is essential in patients with azotemia due to amphotericin B.",
keywords = "5-fluorocytosine, 5-fluorouracil, Candidiasis-Cryptococcosis, Flucytosine",
author = "Bennett, {J. E.}",
year = "1985",
doi = "10.1016/S0399-077X(85)80006-8",
language = "French",
volume = "15",
pages = "332--336",
journal = "Medecine et Maladies Infectieuses",
issn = "0399-077X",
publisher = "Elsevier Masson",
number = "6",

}

TY - JOUR

T1 - La Flucytosine en 1984

AU - Bennett, J. E.

PY - 1985

Y1 - 1985

N2 - Flucytosine is an effective drug in experimental crytococcosis and candidiasis but clinical experience has encountered excessive failures, many of which are traceable to drug resistence. Additional of low dosage amphotericin B has largely solved the problem of drug resistence but has encountered flucytosine toxicity to bone marrow and intestine. Careful monitoring of flucytosine blood levels is essential in patients with azotemia due to amphotericin B.

AB - Flucytosine is an effective drug in experimental crytococcosis and candidiasis but clinical experience has encountered excessive failures, many of which are traceable to drug resistence. Additional of low dosage amphotericin B has largely solved the problem of drug resistence but has encountered flucytosine toxicity to bone marrow and intestine. Careful monitoring of flucytosine blood levels is essential in patients with azotemia due to amphotericin B.

KW - 5-fluorocytosine

KW - 5-fluorouracil

KW - Candidiasis-Cryptococcosis

KW - Flucytosine

UR - http://www.scopus.com/inward/record.url?scp=0022006807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022006807&partnerID=8YFLogxK

U2 - 10.1016/S0399-077X(85)80006-8

DO - 10.1016/S0399-077X(85)80006-8

M3 - Article

AN - SCOPUS:0022006807

VL - 15

SP - 332

EP - 336

JO - Medecine et Maladies Infectieuses

JF - Medecine et Maladies Infectieuses

SN - 0399-077X

IS - 6

ER -